1. Introduction
1.1 Scope of the Study
1.2 Research Report Guidance
1.3 Market Segmentation
1.3.1 North America Systemic Aspergillosis and Systemic Candidasis Market – By Type
1.3.2 North America Systemic Aspergillosis and Systemic Candidasis Market – By Application
1.3.3 North America Systemic Aspergillosis and Systemic Candidasis Market – By Country
2. Systemic Aspergillosis And Systemic Candidasis Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. North America Systemic Aspergillosis and Systemic Candidasis Market– Market Landscape
4.1 Overview
4.2 PEST Analysis
4.3 Expert Opinions
4.4 Clinical Trials Phases of Products Offered by Companies
4.5 Candida Specific Products
5. Systemic Aspergillosis and Systemic Candidasis Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Rise in Prevalence of Fungal Diseases
5.1.2 Rising Hospital Acquired Fungal Infection
5.2 Market Restraints
5.2.1 Increasing Resistance to Antifungal Drugs
5.2.2 Side Effects of Antifungal Drugs
5.3 Market Opportunities
5.3.1 Increase in R&D Activities and Pipeline of New Drug
5.4 Future Trends
5.4.1 Consolidation of Market
5.5 Impact Analysis
6. Systemic Aspergillosis and Systemic Candidasis Market Analysis– by Type
6.1 Overview
6.2 North America Systemic Aspergillosis and Systemic Candidasis Market, by Type, 2019 and 2027 (%)
6.3 Voriconazole
6.3.1 Overview
6.3.2 North America Voriconazole Market Revenue and Forecasts to 2027 (US$ Mn)
6.4 Liposomal Amphotericin B
6.4.1 Overview
6.4.2 North America Liposomal Amphotericin B Market Revenue and Forecasts to 2027 (US$ Mn)
6.5 Systemic Oral Azoles
6.5.1 Overview
6.5.2 North America Systemic Oral Azoles Market Revenue and Forecasts to 2027 (US$ Mn)
6.6 Topical Antifungal Agents
6.6.1 Overview
6.6.2 North America Topical Antifungal Agents Market Revenue and Forecasts to 2027 (US$ Mn)
6.7 Others
6.7.1 Overview
6.7.2 North America Others Market Revenue and Forecasts to 2027 (US$ Mn)
7. Systemic Aspergillosis and Systemic Candidasis Market Analysis– by Application
7.1 Overview
7.2 North America Systemic Aspergillosis and Systemic Candidasis Market, by Type, 2019 and 2027 (%)
7.3 Chronic Pulmonary Aspergillosis (CPA)
7.3.1 Overview
7.3.2 North America Chronic pulmonary aspergillosis (CPA) Market Revenue and Forecasts to 2027 (US$ Mn)
7.4 Allergic Bronchopulmonary Aspergillosis (ABPA)
7.4.1 Overview
7.4.2 North America Allergic bronchopulmonary aspergillosis (ABPA) Market Revenue and Forecasts to 2027 (US$ Mn)
7.5 Gastrointestinal Candidiasis
7.5.1 Overview
7.5.2 North America Gastrointestinal Candidiasis Market Revenue and Forecasts to 2027 (US$ Mn)
7.6 Genitourinary Tract Candidiasis
7.6.1 Overview
7.6.2 North America Genitourinary Tract Candidiasis Market Revenue and Forecasts to 2027 (US$ Mn)
7.7 Others
7.7.1 Overview
7.7.2 North America Others Market Revenue and Forecasts to 2027 (US$ Mn)
8. Systemic Aspergillosis and Systemic Candidiasis Market – Regional Analysis
8.1 Overview
8.1.1 North America: Systemic Aspergillosis and Systemic Candidiasis Market – Revenue and Forecast to 2027 (USD Million)
8.1.2 North America Systemic Aspergillosis and Systemic Candidiasis Market, by Type, 2018–2027 (USD Million)
8.1.3 North America Systemic Aspergillosis and Systemic Candidiasis Market, by Application, 2018–2027 (USD Million)
8.1.4 North America Systemic Aspergillosis and Systemic Candidiasis Market, by Country, 2019 & 2027 (%)
8.1.5 US: Systemic Aspergillosis and Systemic Candidiasis Market – Revenue and Forecast to 2027 (USD Million)
8.1.5.1 US: Systemic Aspergillosis and Systemic Candidiasis Market – Revenue and Forecast to 2027 (USD Million)
8.1.5.2 US: Systemic Aspergillosis and Systemic Candidiasis Market, by Type, 2018–2027 (USD Million)
8.1.5.3 US: Systemic Aspergillosis and Systemic Candidiasis Market, by Application, 2018–2027 (USD Million)
8.1.6 Canada: Systemic Aspergillosis and Systemic Candidiasis Market – Revenue and Forecast to 2027 (USD Million)
8.1.6.1 Canada: Systemic Aspergillosis and Systemic Candidiasis Market – Revenue and Forecast to 2027 (USD Million)
8.1.6.2 Canada: Systemic Aspergillosis and Systemic Candidiasis Market, by Type, 2018–2027 (USD Million)
8.1.6.3 Canada: Systemic Aspergillosis and Systemic Candidiasis Market, by Application, 2018–2027 (USD Million)
8.1.7 Mexico: Systemic Aspergillosis and Systemic Candidiasis Market – Revenue and Forecast to 2027 (USD Million)
8.1.7.1 Mexico: Systemic Aspergillosis and Systemic Candidiasis Market – Revenue and Forecast to 2027 (USD Million)
8.1.7.2 Mexico: Systemic Aspergillosis and Systemic Candidiasis Market, by Type, 2018–2027 (USD Million)
8.1.7.3 Mexico: Systemic Aspergillosis and Systemic Candidiasis Market, by Application, 2018–2027 (USD Million)
9. Impact of COVID-19 Pandemic on North America Systemic Aspergillosis and Systemic Candidiasis Market
9.1 Impact Assessment of COVID-19 Pandemic
10. COMPANY PROFILES
10.1 Novartis AG
10.1.1 Key Facts
10.1.2 Business Description
10.1.3 Products and Services
10.1.4 Financial Overview
10.1.5 SWOT Analysis
10.1.6 Key Developments
10.2 Sanofi
10.2.1 Key Facts
10.2.2 Business Description
10.2.3 Products and Services
10.2.4 Financial Overview
10.2.5 SWOT Analysis
10.2.6 Key Developments
10.3 Pfizer Inc.
10.3.1 Key Facts
10.3.2 Business Description
10.3.3 Products and Services
10.3.4 Financial Overview
10.3.5 SWOT Analysis
10.3.6 Key Developments
10.4 Merck & Co., Inc.
10.4.1 Key Facts
10.4.2 Business Description
10.4.3 Products and Services
10.4.4 Financial Overview
10.4.5 SWOT Analysis
10.4.6 Key Developments
10.5 Bayer AG
10.5.1 Key Facts
10.5.2 Business Description
10.5.3 Products and Services
10.5.4 Financial Overview
10.5.5 SWOT Analysis
10.5.6 Key Developments2
10.6 Astellas Pharma Inc.
10.6.1 Key Facts
10.6.2 Business Description
10.6.3 Products and Services
10.6.4 Financial Overview
10.6.5 SWOT Analysis
10.6.6 Key Developments6
10.7 GlaxoSmithKline plc.
10.7.1 Key Facts
10.7.2 Business Description
10.7.3 Products and Services
10.7.4 Financial Overview
10.7.5 SWOT Analysis
10.7.6 Key Developments
10.8 Abbott
10.8.1 Key Facts
10.8.2 Business Description
10.8.3 Products and Services
10.8.4 Financial Overview
10.8.5 SWOT Analysis6
10.8.6 Key Developments
10.9 Cipla Inc.
10.9.1 Key Facts
10.9.2 Business Description
10.9.3 Products and Services
10.9.4 Financial Overview
10.9.5 Key Developments
10.10 ENZON PHARMACEUTICALS, INC
10.10.1 Key Facts
10.10.2 Business Description
10.10.3 Products and Services
10.10.4 Financial Overview
10.10.5 SWOT Analysis
10.10.6 Key Developments
11. Appendix4
11.1 About the Insight Partners
11.2 Glossary of Terms